| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | decitabine | CTRPv2 | pan-cancer | AAC | 0.031 | 0.3 |
| mRNA | VX-680 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.3 |
| mRNA | BIBR-1532 | CTRPv2 | pan-cancer | AAC | 0.042 | 0.3 |
| mRNA | BMS-754807 | CTRPv2 | pan-cancer | AAC | -0.039 | 0.3 |
| mRNA | navitoclax:pluripotin (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.041 | 0.3 |
| mRNA | etoposide | CTRPv2 | pan-cancer | AAC | 0.034 | 0.3 |
| mRNA | ibrutinib | CTRPv2 | pan-cancer | AAC | 0.046 | 0.3 |
| mRNA | BRD-K64610608 | CTRPv2 | pan-cancer | AAC | -0.043 | 0.4 |
| mRNA | Bortezomib | CTRPv2 | pan-cancer | AAC | 0.039 | 0.4 |
| mRNA | BRD-K13185470 | CTRPv2 | pan-cancer | AAC | -0.073 | 0.4 |